Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1959 Jul;38(7):1222–1227. doi: 10.1172/JCI103897

VARIABILITY IN ABSORPTION OF INSULIN-I131 IN NORMAL AND DIABETIC SUBJECTS AFTER SUBCUTANEOUS AND INTRAMUSCULAR INJECTION*

Edward W Moore 1,†, Marvin L Mitchell 1, Thomas C Chalmers 1
PMCID: PMC293268  PMID: 13664796

Full text

PDF
1222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERSON S. A., YALOW R. S., BAUMAN A., ROTHSCHILD M. A., NEWERLY K. Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest. 1956 Feb;35(2):170–190. doi: 10.1172/JCI103262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERSON S. A., YALOW R. S. Ethanol fractionation of plasma and electrophoretic identification of insulin-binding antibody. J Clin Invest. 1957 May;36(5):642–647. doi: 10.1172/JCI103464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BERSON S. A., YALOW R. S. Studies with insulin-binding antibody. Diabetes. 1957 Sep-Oct;6(5):402–407. doi: 10.2337/diab.6.5.402. [DOI] [PubMed] [Google Scholar]
  4. BURROWS B. A., PETERS T., LOWELL F. C. Physical binding of insulin by gamma globulins of insulin-resistant subjects. J Clin Invest. 1957 Mar;36(3):393–397. doi: 10.1172/JCI103435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. COX R. W., HENLEY E. D., WELSH G. W., 3rd, WILLIAMS R. H. Insulin I-131 metabolism in man; plasma-binding, distribution and degradation. Am J Med. 1956 Sep;21(3):324–338. doi: 10.1016/0002-9343(56)90034-1. [DOI] [PubMed] [Google Scholar]
  6. HAUGAARD N., VAUGHAN M., HAUGAARD E. S., STADIE W. C. Studies of radioactive injected labeled insulin. J Biol Chem. 1954 Jun;208(2):549–563. [PubMed] [Google Scholar]
  7. LEE N. D. Studies on insulin labeled with I 131. Ann N Y Acad Sci. 1957 Aug 30;70(1):94–108. doi: 10.1111/j.1749-6632.1957.tb35381.x. [DOI] [PubMed] [Google Scholar]
  8. SCOTT G. W., PROUT T. E., WEAVER J. A., ASPER S. P. A comparison of the behavior of insulin and insulin labeled with I 131 in serum. Diabetes. 1958 Jan-Feb;7(1):38–45. doi: 10.2337/diab.7.1.38. [DOI] [PubMed] [Google Scholar]
  9. SKOM J. H., TALMAGE D. W. Nonprecipitating insulin antibodies. J Clin Invest. 1958 Jun;37(6):783–786. doi: 10.1172/JCI103664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SKOM J. H., TALMAGE D. W. The role of nonprecipitating insulin antibodies in diabetes. J Clin Invest. 1958 Jun;37(6):787–793. doi: 10.1172/JCI103665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. STADIE W. C., HAUGAARD N., VAUGHAN M. Studies of insulin binding with isotopically labeled insulin. J Biol Chem. 1952 Dec;199(2):729–739. [PubMed] [Google Scholar]
  12. WELSH G. W., 3rd, HENLEY E. D., WILLIAMS R. H., ELGEE N. J. The distribution and metabolism of insulin labeled with radioactive iodine (I131) in normal and diabetic subjects. Diabetes. 1956 Jan-Feb;5(1):15–17. doi: 10.2337/diab.5.1.15. [DOI] [PubMed] [Google Scholar]
  13. YALOW R. S., BERSON S. A. Apparent inhibition of liver insulinase activity by serum and serum fractions containing insulin-binding antibody. J Clin Invest. 1957 May;36(5):648–655. doi: 10.1172/JCI103465. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES